Appraisal of Long-Term Outcomes of Tricuspid Valve Replacement in the Current Perspective [1]
Outcomes of tricuspid valve replacement at a single institution over a 4 decade period were reviewed. A bioprosthesis was used in 82%, and the surgical mortality was nearly 28%. Freedom from structural deterioration was better in the mechanical valve group. Mechanical valves were, however, associated with earlier and more severe morbidity, including a significantly higher incidence of thromboembolic complications.